QQQ   444.84 (+0.00%)
AAPL   170.76 (-1.47%)
MSFT   420.78 (-0.15%)
META   488.94 (-1.00%)
GOOGL   150.75 (-0.08%)
AMZN   180.84 (+0.56%)
TSLA   176.62 (-1.79%)
NVDA   907.43 (+0.55%)
NIO   4.63 (-0.86%)
AMD   181.86 (+1.26%)
BABA   72.56 (+1.35%)
T   17.56 (+0.06%)
F   13.27 (+1.61%)
MU   118.43 (-0.60%)
CGC   9.78 (+2.41%)
GE   175.57 (-2.53%)
DIS   122.69 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.88 (+0.36%)
PYPL   66.85 (+0.42%)
XOM   115.51 (+0.47%)
QQQ   444.84 (+0.00%)
AAPL   170.76 (-1.47%)
MSFT   420.78 (-0.15%)
META   488.94 (-1.00%)
GOOGL   150.75 (-0.08%)
AMZN   180.84 (+0.56%)
TSLA   176.62 (-1.79%)
NVDA   907.43 (+0.55%)
NIO   4.63 (-0.86%)
AMD   181.86 (+1.26%)
BABA   72.56 (+1.35%)
T   17.56 (+0.06%)
F   13.27 (+1.61%)
MU   118.43 (-0.60%)
CGC   9.78 (+2.41%)
GE   175.57 (-2.53%)
DIS   122.69 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.88 (+0.36%)
PYPL   66.85 (+0.42%)
XOM   115.51 (+0.47%)
QQQ   444.84 (+0.00%)
AAPL   170.76 (-1.47%)
MSFT   420.78 (-0.15%)
META   488.94 (-1.00%)
GOOGL   150.75 (-0.08%)
AMZN   180.84 (+0.56%)
TSLA   176.62 (-1.79%)
NVDA   907.43 (+0.55%)
NIO   4.63 (-0.86%)
AMD   181.86 (+1.26%)
BABA   72.56 (+1.35%)
T   17.56 (+0.06%)
F   13.27 (+1.61%)
MU   118.43 (-0.60%)
CGC   9.78 (+2.41%)
GE   175.57 (-2.53%)
DIS   122.69 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.88 (+0.36%)
PYPL   66.85 (+0.42%)
XOM   115.51 (+0.47%)
QQQ   444.84 (+0.00%)
AAPL   170.76 (-1.47%)
MSFT   420.78 (-0.15%)
META   488.94 (-1.00%)
GOOGL   150.75 (-0.08%)
AMZN   180.84 (+0.56%)
TSLA   176.62 (-1.79%)
NVDA   907.43 (+0.55%)
NIO   4.63 (-0.86%)
AMD   181.86 (+1.26%)
BABA   72.56 (+1.35%)
T   17.56 (+0.06%)
F   13.27 (+1.61%)
MU   118.43 (-0.60%)
CGC   9.78 (+2.41%)
GE   175.57 (-2.53%)
DIS   122.69 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.88 (+0.36%)
PYPL   66.85 (+0.42%)
XOM   115.51 (+0.47%)
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

$0.86
+0.04 (+4.27%)
(As of 11:25 AM ET)
Today's Range
$0.82
$0.88
50-Day Range
$0.81
$2.30
52-Week Range
$0.70
$8.30
Volume
12,148 shs
Average Volume
177,300 shs
Market Capitalization
$709,650.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AMPE stock logo

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

AMPE Stock Price History

AMPE Stock News Headlines

Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
Ampio Pharmaceuticals Inc
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts
Ampio Pharmaceuticals Announces Reverse Stock Split
AMPE - Ampio Pharmaceuticals, Inc.
See More Headlines
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
$-16,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$15.62 per share

Miscellaneous

Free Float
805,000
Market Cap
$680,600.00
Optionable
No Data
Beta
2.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Michael A. Martino (Age 67)
    CEO & Director
    Comp: $548.14k
  • Dr. David Bar-Or M.D. (Age 75)
    Founder & Chairman of Scientific Advisory Board
    Comp: $145.6k
  • Mr. Daniel G. Stokely CPA (Age 60)
    CFO, Corporate Secretary & Treasurer
    Comp: $346.73k
  • April Ramirez
    Clinical Trial Manager

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed in 2024?

Ampio Pharmaceuticals' stock was trading at $2.05 at the start of the year. Since then, AMPE shares have decreased by 60.0% and is now trading at $0.82.
View the best growth stocks for 2024 here
.

When is Ampio Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our AMPE earnings forecast
.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.40) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.40).

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals shares reverse split before market open on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Dan Stokely, David R Stevens, Holli Cherevka, J Kevin Buchi, Michael A Martino and Philip H Coelho.
View institutional ownership trends
.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AMPE) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners